Strategic Research Agreement — Round 2
Funds investigator-initiated type 1 diabetes projects spanning early detection, prevention, and advanced therapeutic development pipelines.
Breakthrough T1D's Strategic Research Agreement (SRA) program funds investigator-initiated research across all five of the organisation's scientific priority areas — early detection, disease-modifying therapies, cell therapies, improving lives, and growing the research community — through a cooperative partnership model that pairs academic investigators with Breakthrough T1D staff scientists. Breakthrough T1D, the US 501(c)(3) that rebranded from JDRF in June 2024, estimates that 1.5 million Americans and 9.5 million people worldwide live with type 1 diabetes, and it directs research investments through academic and industry partnerships rather than operating its own laboratories. SRA awards are flexible in both budget and duration; detailed financial terms are published in the organisation's Grant Handbook at breakthrought1d.org/granthandbook.
FY27 Round 2 is the second of the two annual SRA Project Concept cycles in fiscal year 2027. The Project Concept (letter of intent) deadline for Round 2 is May 6, 2027, with notification of invited applicants on June 17, 2027. The application process follows an identical two-stage structure to Round 1: a Project Concept gate followed by a full application only for invited investigators. Awardees commit to quarterly milestone reporting and direct interaction with Breakthrough T1D scientists as conditions of continued funding.
The program is open to academic investigators at eligible institutions globally — US residency is not required. International applicants should review the international funding eligibility guidance published by Breakthrough T1D UK. All submissions for both SRA rounds are processed through the SmartSimple RMS360 portal at breakthrought1d.smartsimple.us. Investigators considering the SRA should submit a Project Concept that explicitly links proposed research to one or more of Breakthrough T1D's five priority areas and demonstrates the investigator's capacity to engage productively with funder scientists throughout the award period.
Investigator-initiated type 1 diabetes research across all five Breakthrough T1D priority areas, structured as a cooperative milestone-based partnership with funder scientists.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline